comparemela.com

Latest Breaking News On - Drug selection - Page 10 : comparemela.com

Nirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial

Nirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Iraq approves Sinopharm, AstraZeneca COVID-19 vaccines for emergency use against COVID-19

Last Updated: Iraq Approves Sinopharm, AstraZeneca COVID-19 Vaccines For Emergency Use Against COVID-19 Iraq authorities approve the coronavirus vaccines by UK-Swedish company AstraZeneca and China s Sinopharm for emergency use On Tuesday, January 19, Iraqi authorities approved the emergency use of coronavirus vaccines by UK-Swedish company AstraZeneca and China s Sinopharm. In a statement, the Iraqi Ministry of Health said, “The National Authority for Drug Selection has approved vaccines by the UK s AstraZeneca and China s Sinopharm for emergency use to fight the coronavirus pandemic. Earlier, the ministry had granted permission to use Pfizer vaccine against the deadly virus.  All that you need to know 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.